A Case Report on Management and Treatment of a Male Patient Suffering from Interstitial Lung Disease (ILD) or Pulmonary Disease
Asian Journal of Medicine and Health,
The present study is a case report of a man who was initially diagnosed with “interstitial lung disease” (ILD) or pulmonary disease which is supposed to be an umbrella term for a large group of disorders responsible for scattered fibrosis of the lungs. It is an irreversible scenario. The causative factors for the above mentioned diseased conditions are yet to be found, and all of them are grouped under interstitial pneumonias. The patient underwent detailed clinical investigations on several parameters such as CT pulmonary angiography, Lower limb venous Doppler, D-dimer test, Real Time polymerase chain reaction (RT PCR) for the novel SARS-CoV -2, Ultra-sonography (USG) of the abdomen, C-reactive proteins (CRP), complete blood count (CBC), Legionella antigen test, specific Mycoplasma IgM antibody assay, the total parameters of the renal functioning test of the blood serum, pro-calcitonin (PCT) level, and the acute coronary syndrome panel (POCT). After detailed investigations the patient was diagnosed with ILD and medications specific to the disease was prescribed. The medications that were prescribed were ceftriaxone with injection pantoprazole, paracetamol, levofloxacin, enoxaparin, amiodiprine, and furosemide. He was also advised to continue his own other medications along with these and contact at the emergency services of the hospital in case of any urgency. He was also advised for follow up visit. The patient responded to the applied therapeutic interventions and survived from the suffering. Thus, here a detailed case reporting has been conducted with the particular disease along with its diagnosis and management.
- Interstitial lung disease (ILD)
- CT pulmonary angiography
How to Cite
Mizuno S, Takiguchi Y, Fujikawa A, Motoori K, Tada Y, Kurosu K, Sekine Y, Yanagawa N, Hiroshima K, Muraoka K, Mitsushima T. Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology. 2009;14(3):377-83.
Nagata K, Tomii K, Otsuka K, Tachikawa R, Otsuka K, Takeshita J, Tanaka K, Matsumoto T, Monden K. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health‐related quality of life in patients with interstitial lung disease. Respirology. 2012;17(3):506-12.
Pepys MB, Hirschfield GM. C-reactive protein: a critical update. The Journal of clinical investigation. 2003;111(12):1805-12.
George-Gay B, Parker K. Understanding the complete blood count with differential. Journal of Peri Anesthesia Nursing. 2003;18(2):96-117.
Hung TL, Li MC, Wang LR, Liu CC, Li CW, Chen PL, Syue LS, Lee NY, Ko WC. Legionnaires' disease at a medical center in southern Taiwan. Journal of microbiology, immunology and infection. 2018;51(3):352-8.
Qu J, Gu L, Wu J, Dong J, Pu Z, Gao Y, Hu M, Zhang Y, Gao F, Cao B, Wang C. Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC infectious diseases. 2013;13(1):1-6.
Vikerfors T, Brodin G, Grandien M, Hirschberg L, Krook A, Pettersson CA. Detection of specific IgM antibodies for the diagnosis of Mycoplasma pneumoniae infections: a clinical evaluation. Scandinavian journal of infectious diseases. 1988;20(6):601-10.
Kaiserova E, Kolenova A. The role of CRP, PCT, IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haemato-oncological patients. Neoplasma. 2016;63(5).
Lai L, Lai Y, Wang H, Peng L, Zhou N, Tian Y, Jiang Y, Gong G. Diagnostic accuracy of procalcitonin compared to C-reactive protein and interleukin 6 in recognizing gram-negative bloodstream infection: a meta-analytic study. Disease markers. 2020;2020.
Keramidaris D, Koronakis N, Lagoudianakis EE, Pappas A, Koukoutsis I, Chrysikos I, Karavitis G, Toutouzas K, Manouras A. Procalcitonin in patients with colorectal cancer. J BUON. 2013;18(3):623-8.
Rao LV, Ekberg BA, Connor D, Jakubiak F, Vallaro GM, Snyder M. Evaluation of a new point of care automated complete blood count (CBC) analyzer in various clinical settings. Clinica Chimica Acta. 2008;389(1-2):120-5.
Chan KH, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim J. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: a retrospective, hospital-based observational case series. Diabetes research and clinical practice. 2020;166:108279.
Bergonse FN, Nico MM, Kavamura MI, Sotto MN. Miliary osteoma of the face: a report of 4 cases and review of the literature. CUTIS-NEW YORK-. 2002;69(5):383-90.
Schwaiblmair M, Behr W, Haeckel T, Märkl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. The open respiratory medicine journal. 2012;6:63.
Abstract View: 98 times
PDF Download: 23 times